LON:EVG Evgen Pharma (EVG) Share Price, News & Analysis GBX 0.80 0.00 (0.00%) (As of 04/25/2024) Add Compare Share Share Today's Range 0.80▼ 0.8050-Day Range 0.80▼ 0.8052-Week Range 0.70▼ 4.05Volume227,410 shsAverage Volume1.73 million shsMarket Capitalization£3.42 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartStock AnalysisChart Get Evgen Pharma alerts: Email Address Ad Paradigm PressKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move… Click here now and learn how to prepare. About Evgen Pharma Stock (LON:EVG)Evgen Pharma plc, a clinical stage drug development company, focuses on the development of sulforaphane-based medicines for the treatment of cancer and inflammatory diseases. It develops its products using Sulforadex, a sulforaphane stabilization technology. The company's lead product is SFX-01, that is in Phase II clinical trials for the treatment of metastatic breast cancer; and in Phase Ib/IIa clinical trials for the treatment of glioblastoma, as well as in preclinical stage for the treatment of haematological malignancies and analogues. It also provides out-licensing of its technology services. Evgen Pharma plc was incorporated in 2014 and is headquartered in Nether Alderley, the United Kingdom.Read More EVG Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EVG Stock News HeadlinesAugust 12, 2024 | finance.yahoo.comPROTAC Market is Expected to Showcase Significant Growth During the Study Period (2020–2034) | DelveInsightAugust 1, 2024 | finance.yahoo.comGlobal Cancer Supportive Care Drugs Market to Cross 17 Billion Mark by 2030| DelveInsightSeptember 7, 2024 | Timothy Sykes (Ad)Tim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…April 4, 2024 | lse.co.ukTRADING UPDATES: Northcoders launches bootcamp; Schroder investsMarch 20, 2024 | marketwatch.comEvgen to Raise Up to $2.4 Mln; to Change Name After Acquiring Chronos TherapeuticsFebruary 27, 2024 | lse.co.ukEvgen Pharma finds evidence of SFX-01 activity in colon cancer modelsFebruary 14, 2024 | msn.comPharma middlemen face govt. scrutiny over generic drug shortagesJanuary 26, 2024 | lse.co.ukEvgen Pharma Share ChatSeptember 7, 2024 | Timothy Sykes (Ad)Tim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…December 4, 2023 | finance.yahoo.comMetastatic HR+/HER2− Breast Cancer Market is Expected to Showcase a Significant Growth at a CAGR of 9.3% by 2032, Predicts DelveInsightOctober 31, 2023 | finance.yahoo.comEvgen Pharma "delighted" with cash position after promising first halfSeptember 5, 2023 | lse.co.ukEvgen Pharma hires interim CFO from Faron, chair to retire this monthSeptember 5, 2023 | marketwatch.comEvgen Pharma Chair Barry Clare Steps Down; Appoints New Interim Chair, Interim CFOAugust 15, 2023 | marketwatch.comEvgen Pharma Shares Rise on Positive SFX-01 Tablet ReportAugust 2, 2023 | marketwatch.comEvgen Pharma Shares Fall on Ending of License DealJune 19, 2023 | lse.co.ukEvgen collaborator receives grant from KWF Dutch Cancer SocietyJune 7, 2023 | lse.co.ukEvgen Pharma confident amid Stalicla deal; CFO Moulson to retireMarch 22, 2023 | marketwatch.comEvgen Pharma Results From SFX-01 Tablet Trial Meet ExpectationsSee More Headlines Receive EVG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evgen Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings6/15/2020Today9/07/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryFinancial Services Current SymbolLON:EVG CUSIPN/A CIKN/A Webevgen.com Phone+44-151-7053532FaxN/AEmployees10Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-3,350,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-60.57% Return on Assets-45.52% Debt Debt-to-Equity RatioN/A Current Ratio10.39 Quick Ratio23.15 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowGBX 0.47 per share Price / Cash Flow1.71 Book ValueGBX 1 per share Price / Book0.80Miscellaneous Outstanding Shares427,350,000Free FloatN/AMarket Cap£3.42 million OptionableNot Optionable Beta1.44 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesDr. Huw Jones BSc (Age 65)Ph.D., CEO & Executive Director Comp: $304.73kMr. Toni Haenninen (Age 47)CFO & Director Dr. Helen KuhlmanChief Business OfficerDr. Glen Clack FFPMM.D., Chief Medical OfficerKey CompetitorsGlenveagh PropertiesLON:GLVContangoLON:CGOTwo Shields Investments Plc (TSI.L)LON:TSIMayan EnergyLON:MYNMinoan GroupLON:MINView All CompetitorsInsidersToni HänninenBought 1,000,000 shares on 4/5/2024Total: £1 M ($1.00/share) EVG Stock Analysis - Frequently Asked Questions How have EVG shares performed this year? Evgen Pharma's stock was trading at GBX 1.60 at the start of the year. Since then, EVG stock has decreased by 50.0% and is now trading at GBX 0.80. View the best growth stocks for 2024 here. How were Evgen Pharma's earnings last quarter? Evgen Pharma plc (LON:EVG) released its quarterly earnings data on Monday, June, 15th. The company reported ($2.10) EPS for the quarter, hitting analysts' consensus estimates of ($2.10). How do I buy shares of Evgen Pharma? Shares of EVG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of Evgen Pharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that Evgen Pharma investors own include MOTIF BIO PLC/S (MTFB), Capital & Counties Properties PLC (CAPC), Obtala (OBT), Tertiary Minerals (TYM), Veltyco Group (VLTY), Atalaya Mining (AYM) and AllianceBernstein Global High Income Fund (AWF). This page (LON:EVG) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evgen Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Evgen Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.